List view / Grid view
21 May 2012 | By Boehringer Ingelheim
Olodaterol significantly improved lung function (FEV 1) for at least 24 hours compared to placebo...
21 May 2012 | By Phenomenex Inc
Phenomenex Inc., introduces Phree Phospholipid Removal Plates for fast cleanup of plasma samples...
21 May 2012 | By Merck
The U.S. FDA approved a labeling update for ISENTRESS® Film-coated Tablets to include 156-week data from the STARTMRK study...
21 May 2012 | By H. Lundbeck A/S
Lundbeck increases its share capital by 593 shares as a result of employee warrant exercise...
18 May 2012 | By GlaxoSmithKline
Judges of the GSK IMPACT Awards could not choose one overall winner for the awards...
18 May 2012 | By Biogen Idec / Elan Corporation plc
Use of biomarker has potential to advance personalised treatment for MS patients...
18 May 2012 | By Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals announce results of an investigational Phase 3 study...
18 May 2012 | By Pfizer
Results of studies on Lyrica® announced...
18 May 2012 | By GlaxoSmithKline
GSK believes its offer represents full and fair value and is in the best interests of both companies’ shareholders...
18 May 2012 | By Daiichi Sankyo
ArQule and Daiichi Sankyo announced that recruitment of patients has been completed...
17 May 2012 | By Novartis
Results from pivotal Phase III GLOW2 study...
17 May 2012 | By Teva Pharmaceutical Industries Ltd
“Dr. Phillip Frost has the Board’s full support..."
16 May 2012 | By Amgen
Updated results from a Phase 2 study...
16 May 2012 | By GlaxoSmithKline
GSK and Theravance, Inc. announced that following approval by Theravance...
16 May 2012 | By Catalent Pharma Solutions
“This competition allows us to acknowledge some of the world’s best emerging talent..."
